GlaxoSmithKline Q2 2016 Earnings Results

GlaxoSmithKline reports Q2 2016 financial results as of July 27, 2016, with new product portfolio showing robust growth across Rx, vaccines, and consumer healthcare segments. The presentation outlines GSK's strategic direction with emphasis on innovative medicines, vaccines including Bexsero and Menveo, and over-the-counter products generating significant year-over-year growth.